19.09.2018
- The biopharmaceutical industry has grown impressively in recent years, with its global compound growth rate (CAGR) estimated to reach 8.5% between 2018-2023, outstripping...
19.09.2018
- Despite the favorable economic environment, the global economic risk factors have intensified against the background of record global debt and a rise in geopolitical risk. Amid...
17.05.2018
- US drug development specialist Catalent Pharma Solutions and Valerius Biopharma, a Swiss biopharmaceutical company providing interchangeable treatment options for high-priced...
26.04.2018
- Mylan has joined forces with Japan’s Fujifilm Kyowa Kirin Biologics to commercialize a biosimilar to Abbvie’s Humira (adalimumab) that has been developed by the Japanese company...
25.01.2018
- US healthcare giant Johnson & Johnson has just been handed its second defeat in patent litigation this month. On Jan. 23, a US appeals court hearing J&J’s challenge to a lower...
24.01.2018
- Sandoz, the generics subsidiary of Novartis, is collaborating with Biocon, an India-based biopharmaceuticals producer, to develop, manufacture and commercialize multiple...
07.12.2017
- The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...
24.11.2017
- In a suit filed in the state of Delaware, the Swiss-based Roche Holding is suing Pfizer to block the future marketing a biosimilar of its breast-cancer drug Herceptin in the US...
